| |
Physicians Views Of Formularies: Implications For Medicare Drug Benefit Design
Bruce E. Landon,
James D. Reschovsky and
David Blumenthal
As Congress considers introducing a drug benefit for Medicare, it will more than likely adopt a program that uses a formulary. We examined data from the Community Tracking Study Physicians Survey, a large, nationally representative study of physicians, to learn about physicians views of formularies. Our results suggest that several aspects of formularies are associated with physicians positive views about them. Policymakers should consider imposing limits on the number of competing Medicare formularies operating in a particular area, promoting the adoption and use of information technology, and incorporating financial incentives for physicians to adhere to formularies.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C.-W. Tseng, C. M. Mangione, R. H. Brook, E. Keeler, and R. A. Dudley
Identifying Widely Covered Drugs and Drug Coverage Variation Among Medicare Part D Formularies
JAMA,
June 20, 2007;
297(23):
2596 - 2602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Pham, G. C. Alexander, and A. S. O'Malley
Physician Consideration of Patients' Out-of-Pocket Costs in Making Common Clinical Decisions
Arch Intern Med,
April 9, 2007;
167(7):
663 - 668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Koyanagi, S. Forquer, and E. Alfano
Medicaid Policies To Contain Psychiatric Drug Costs
Health Aff.,
March 1, 2005;
24(2):
536 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|